At the 1st International Conference on Young Women’s Breast Cancer and Health in Lisbon in October 2024, Prof Neeme Tõnisson presented the results of the BRIGHT Estonian arm. Additionally, two posters, “Genetic Risk-Based Breast Cancer Screening Service Model for Younger Women in Estonia” and “Epidemiological and Radiologic Factors in the Portuguese BRIGHT Study Cohort – Preliminary Results,” were presented by the BRIGHT Consortium partners.

October is recognised as Breast Cancer Awareness Month, dedicated to raising awareness about breast cancer prevention. The month concluded with a significant event—the 1st International Conference on Young Women’s Breast Cancer and Health in Lisbon. Representing Estonia, Prof. Neeme Tõnisson presented the genetic risk-based personalised breast cancer prevention approach developed, researched, and clinically implemented through the EIT Health BRIGHT project in Estonia. His presentation was titled: “BRIGHT International Consortium Project: Polygenic Risk Score in Early Breast Cancer Detection”.

Breast cancer is, unfortunately, becoming the most common cancer globally, with incidence rates increasing, including among younger women. However, the positive news is that the likelihood of developing breast cancer can be reduced by addressing risk factors, and, with timely detection, it can be treated successfully.

It was inspiring to witness discussions at the conference, particularly from women’s and patient organisations, highlighting that for effective breast cancer prevention and early detection, women need to understand their personal risk levels. Healthcare professionals must also provide personalised prevention guidelines tailored to these risks.